News
-
-
-
-
-
-
PRESS RELEASE
Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income
Viromed Medical AG reports significant revenue increase and positive net income in 2025 financial year. CEO Uwe Perbandt emphasizes strategic milestones achieved -
-
-
-
PRESS RELEASE
Viromed Medical AG: ViroCAP® med successfully completes regulatory process as a Class IIa medical device – starting signal for market launch at the European Wound Congress 2026
Viromed Medical AG announces ViroCAP® med's successful completion of the regulatory process as a Class IIa medical device, paving the way for market launch at the European Wound Congress 2026. Cold plasma technology for wound treatment
